MARKET

NRSN

NRSN

Neurosense Therapeutics Ltd
NASDAQ
1.690
-0.070
-3.98%
Closed 19:57 11/13 EST
OPEN
1.720
PREV CLOSE
1.760
HIGH
1.780
LOW
1.590
VOLUME
18.30K
TURNOVER
123.27K
52 WEEK HIGH
25.40
52 WEEK LOW
1.100
MARKET CAP
3.21M
P/E (TTM)
-0.8212
1D
5D
1M
3M
1Y
5Y
1D
NeuroSense Therapeutics Consensus Price Target Increased by 15.35% to $113.39
NASDAQ · 6d ago
Weekly Report: what happened at NRSN last week (1102-1106)?
Weekly Report · 6d ago
NeuroSense Adds New Data To PrimeC Application, Delays Health Canada Filing To March 2027
Benzinga · 11/02 18:51
NeuroSense Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 11/02 17:41
HC Wainwright & Co. Downgrades NeuroSense Therapeutics to Neutral
Benzinga · 11/02 17:32
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 11/02 17:05
NeuroSense downgraded to Neutral from Buy at H.C. Wainwright
TipRanks · 11/02 16:45
NeuroSense downgraded at H.C. Wainwright on extended PrimeC timelines
TipRanks · 11/02 16:45
More
About NRSN
NeuroSense Therapeutics Ltd. is an Israel-based clinical-stage pharmaceutical company engaged in the development of therapies for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The Company’s lead product candidate, PrimeC, is an oral fixed-dose combination therapy designed for the treatment of ALS. In addition to PrimeC, the Company conducts research and development activities focused on neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease. The Company develops pharmaceutical products and therapeutic solutions aimed at addressing unmet medical needs in neurological diseases and related central nervous system disorders. The Company also advances therapies for rare neurological conditions.

Webull offers Neurosense Therapeutics Ltd stock information, including NASDAQ: NRSN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRSN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRSN stock methods without spending real money on the virtual paper trading platform.